- Half Year 2024 Idorsia Ltd Earnings Call TranscriptJul 25, 2024CHF2.74 (+18.17%)Earnings
- Idorsia Ltd to Discuss the TRYVIO FDA Approval TranscriptMar 20, 2024
- Idorsia Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Idorsia Ltd Earnings Call TranscriptOct 24, 2023CHF1.62 (-13.10%)Earnings
- Half Year 2023 Idorsia Ltd Earnings Call TranscriptJul 25, 2023CHF6.43 (-5.72%)Earnings
- Sosei Group Corp to Acquire Idorsia Ltd Pharmaceuticals Business in Japan and APAC TranscriptJul 20, 2023
- Q1 2023 Idorsia Ltd Earnings Call TranscriptApr 25, 2023CHF8.99 (-6.98%)Earnings
- Full Year 2022 Idorsia Ltd Earnings Call TranscriptFeb 07, 2023CHF12.51 (-8.89%)Earnings
- Idorsia Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Idorsia Ltd Cenerimod Phase 3 Initiation Webcast TranscriptDec 15, 2022
- Idorsia Ltd Conference Call TranscriptNov 08, 2022
- Q3 2022 Idorsia Ltd Earnings Call TranscriptOct 25, 2022CHF13.95 (+3.95%)Earnings
- Half Year 2022 Idorsia Ltd Earnings Call TranscriptJul 26, 2022CHF11.42 (+0.62%)Earnings
- Idorsia Ltd To Discuss PRECISION top-line results TranscriptMay 24, 2022
- Full Year 2021 Idorsia Ltd Earnings Call TranscriptFeb 08, 2022CHF19.88 (-4.70%)Earnings
- Idorsia Ltd To Discuss Daridorexant Phase 3 program published in The Lancet Neurology Call TranscriptJan 20, 2022
- Idorsia Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Half Year 2021 Idorsia Ltd Earnings Call TranscriptJul 27, 2021CHF24.6 (-1.99%)Earnings
- Idorsia Ltd To Discuss Phase 3 Program -Corporate Call TranscriptJun 28, 2021
- Idorsia Ltd - Pre Recorded Special Call TranscriptMar 10, 2021
- Full Year 2020 Idorsia Ltd Earnings Call TranscriptFeb 04, 2021CHF26.68 (-1.11%)Earnings
- Idorsia Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Half Year 2020 Idorsia Ltd Earnings Call TranscriptJul 23, 2020CHF26.6 (+0.23%)Earnings
- Idorsia Ltd - Special Call TranscriptJul 06, 2020
- Idorsia Ltd - Special Call TranscriptApr 20, 2020
- Full Year 2019 Idorsia Ltd Earnings Call TranscriptFeb 06, 2020CHF32.23 (-1.26%)Earnings
- Half Year 2019 Idorsia Ltd Earnings Call TranscriptJul 23, 2019CHF21.39 (-7.52%)Earnings
Idorsia Ltd at JPMorgan Healthcare Conference Transcript
Good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the Idorsia presentation. So you're going to hear from Idorsia CEO, Jean-Paul Clozel, and we have about a 20-minute presentation, and then we'll have 15, 20 minutes for your questions, which we're going to take in the same room. So with that said, thanks very much for joining us today, Jean-Paul, looking forward to the presentation.
Thank you. You just have swallowed 30 seconds from the presentation. Okay. So good afternoon, everybody. I think Idorsia -- for Idorsia, the year 2023 is going to be really very interesting. And this is really because of all the work, and after this disclaimer, because of all the work that we did in 2022. And in this 2022 year, we achieved a lot.
We achieved a lot because we became a commercial company. Idorsia launched QUVIVIQ,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)